Skip to content

Beam Therapeutics

Overview

Beam Named a TIME100 Most Influential Company, TIME100 Industry Leader, & CEO John Evans Recognized on TIME100 Health List Base editing is an emerging class of investigational precision genetic medicines designed to overcome the limitations of existing approaches and expand the potential of genetic medicine. Our delivery strategy is to establish a suite of clinically validated technologies, including electroporation, nonviral and viral delivery modalities.

Hiring at Beam Therapeutics

34 live roles · 5 roles added to DeepTechJobs in the last 14 days

Where they are hiring

  • Cambridge, United States20
  • Durham, United States11

Roles by function

  • Quality & Test5
  • Legal & Compliance4
  • Manufacturing & Operations4
  • Marketing2
  • Research & Science2
  • Facilities & EHS1

Of 22 classified roles

Live roles (34)

Showing 31–34 of 34 live roles